Chronic plaque psoriasis Trials in Waterloo, Canada
Conditions / Chronic plaque psoriasis / Waterloo, Canada
Clinical trials for Chronic plaque psoriasis investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03598790 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | — |
| NCT03410992 | A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | — |
| NCT03412747 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | — |
| NCT00799877 | Chronic Plaque Psoriasis (Ps) Registry | COMPLETED | — |
| NCT02581345 | Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis | COMPLETED | PHASE3 |
| NCT03370133 | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | — |
| NCT03982394 | Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | — |
| NCT03536884 | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | — |
| NCT04286607 | Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT01358578 | Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis | COMPLETED | PHASE3 |